Administration of NAC can also lead to a reduction in C-reactive protein (CRP) and serum malondialdehyde (MDA) levels, which are markers of inflammation and oxidative stress, in patients with SLE [52]. The gene discussed is CRP; the disease is systemic lupus erythematosus.